UB Paderborn / Katalog / Suche / in CDI

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

Journal of hepatology, 2020-12, Vol.73 (6), p.1415-1424

2020

Link zum Volltext

Verfügbarkeit prüfen

LOXL2-A New Target in Antifibrogenic Therapy?

International journal of molecular sciences, 2019-04, Vol.20 (7), p.1634

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis

Hepatology (Baltimore, Md.), 2017-05, Vol.65 (5), p.1693-1707

2017

Link zum Volltext

Verfügbarkeit prüfen

Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell-Mediated Rejection After Liver Transplantation

Transplantation, 2020-03, Vol.104 (3), p.562

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

Hepatology (Baltimore, Md.), 2015-08, Vol.62 (2), p.575-583

2015

Link zum Volltext

Verfügbarkeit prüfen

Protective measures against Omicron could be more effective than cilgavimab/tixagevimab in liver transplant recipients

Revista española de enfermedades digestivas, 2022-12, Vol.114 (12), p.769

2022

Link zum Volltext

Verfügbarkeit prüfen

High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease

Liver international, 2023-07, Vol.43 (7), p.1446-1457

2023

Link zum Volltext

Verfügbarkeit prüfen

CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients

Infectious diseases (London, England), 2023-09, Vol.55 (9), p.646-652

2023

Link zum Volltext

Verfügbarkeit prüfen

Binge drinking: Burden of liver disease and beyond

World journal of hepatology, 2015-11, Vol.7 (27), p.2703-2715

2015

Link zum Volltext

Verfügbarkeit prüfen

Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors

Hepatology research, 2021-10, Vol.51 (10), p.1064-1072

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey

Digestive and liver disease, 2019-01, Vol.51 (1), p.95-103

2019

Link zum Volltext

Verfügbarkeit prüfen

No evidence of association between inherited thrombophilia and increased risk of liver fibrosis

United European gastroenterology journal, 2023-12, Vol.11 (10), p.1010-1020

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma betatrophin levels in patients with liver cirrhosis

World journal of gastroenterology : WJG, 2015-10, Vol.21 (37), p.10662-10668

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

Journal of clinical medicine, 2021-10, Vol.10 (21), p.4885

2021

Link zum Volltext

Verfügbarkeit prüfen

Congestive Hepatopathy

International journal of molecular sciences, 2020-12, Vol.21 (24), p.9420

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Journal of clinical medicine, 2019-08, Vol.8 (8), p.1242

2019

Link zum Volltext

Verfügbarkeit prüfen

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver

Gastroenterología y hepatología, 2017-10, Vol.40 (8), p.538-580

2017

Link zum Volltext

Verfügbarkeit prüfen

Cirrhosis, a Global and Challenging Disease

Journal of clinical medicine, 2022-11, Vol.11 (21), p.6512

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding

World journal of clinical cases, 2018-11, Vol.6 (13), p.611-623

2018

Link zum Volltext

Verfügbarkeit prüfen

Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease

Revista española de enfermedades digestivas, 2024-05, Vol.116 (5), p.287-288

2024

Link zum Volltext

Verfügbarkeit prüfen

Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review

Journal of clinical medicine, 2022-10, Vol.11 (21), p.6435

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of heat pre-treatment on BSA tryptic hydrolysis and peptide release

Food chemistry, 2016-07, Vol.202, p.40-48

2016

Link zum Volltext

Verfügbarkeit prüfen

Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases

Hepatobiliary surgery and nutrition, 2023-02, Vol.12 (1), p.105-109

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy

Revista española de enfermedades digestivas, 2017-01, Vol.109 (1), p.17-25

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

LOXL2-A New Target in Antifibrogenic Therapy?

Non-invasive tests for clinically significant portal hypertension after HCV cure

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis

Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell-Mediated Rejection After Liver Transplantation

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

Protective measures against Omicron could be more effective than cilgavimab/tixagevimab in liver transplant recipients

High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease

CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients

Binge drinking: Burden of liver disease and beyond

Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey

No evidence of association between inherited thrombophilia and increased risk of liver fibrosis

Plasma betatrophin levels in patients with liver cirrhosis

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

Congestive Hepatopathy

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver

Cirrhosis, a Global and Challenging Disease

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding

Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease

Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review

Influence of heat pre-treatment on BSA tryptic hydrolysis and peptide release

Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy

Suchergebnisse filtern